Xenon Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript
Ladies and gentlemen, the program is about to begin. (Operator Instructions) At this time, it is my pleasure to turn the program over to your host, Jason Gerberry.
Good day, everybody. Thanks so much for joining us at the BofA Biotech conference that's being conducted virtually. My name is Jason Gerberry. I'm one of the biotech analysts, and I'm pleased to be introducing Xenon Pharmaceuticals and CEO, Ian Mortimer; and CFO, Sherry Aulin. So thanks so much to both of you for first all for joining us at the event.
Thanks, Jason.
Questions & Answers
So obviously, the first place that most of these conversations for you, I imagine, start is with your lead drug 1101, your potassium channel opener for focal-onset epilepsy
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
